Log in  First Connection?

SchizophreniaArchives

A study on Mahjong intervention to improve cognitive impairment in patients with schizophrenia: a pilot, single-blind, randomized, controlled trial
Schizophrenia
 5 min.

 Published on 11/11/2025 |  Original article (Full-text)  | Hu Renqin et al. | BMC Psychiatry 2025; 25(1): 1070

Mental disorders remain one of the top ten global burdens, and schizophrenia has one of the highest measured years lived with disability among all diseases, injuries, and risk factors [1]. Cognitive deficits have long been considered a core symptom of schizophrenia and are significant factors leading...

Schizophrenia and sensory modulation problems: the relationship between severity, depression and sensory responsiveness
Schizophrenia
 5 min.

 Published on 04/11/2025 |  Original article (Full-text)  | Şahin Can Merve et al. | BMC Psychiatry 2025; 25(1): 1038

The concept of sensory integration (SI), defined by Dr. Jean Ayres in the 1970s, refers to the ability to receive, process, organize, and respond to stimuli from one’s body and environment by generating appropriate neurological and behavioral reactions [1]. Sensory integration underlies sensory...

Decreased levels of platelet-derived growth factor subtypes and superoxide dismutase isoenzymes in early-onset schizophrenia
Schizophrenia
 6 min.

 Published on 28/10/2025 |  Original article (Full-text)  | Yang Haidong et al. | Schizophrenia 2025; 11(1): 128

Schizophrenia is a severe mental disorder with a global prevalence of approximately 1%. Symptom expression is highly heterogeneous, but core symptoms include disturbances in thought, perception, affect, and behavior that markedly interfere with education, social life, and career aspirations1. Early-onset...

Primary and secondary caregiver burden of cognitive impairment associated with schizophrenia: a qualitative study based on caregiver interviews
Schizophrenia
 5 min.

 Published on 21/10/2025 |  Original article (Full-text)  | Tulliez Sébastien et al. | Schizophrenia 2025; 11(1): 127

Schizophrenia is a complex, chronic psychiatric disorder that presents many challenges; impairments in daily functioning and quality of life can be difficult for patients to manage, and the impact of these challenges often extends to caregivers1, 2–3. In addition, the role of society in supporting...

Effect of olanzapine on changes in serum complement factors levels in patients with first-episode schizophrenia
Schizophrenia
 6 min.

 Published on 14/10/2025 |  Original article (Full-text)  | Cao Yin et al. | BMC Psychiatry 2025; 25(1): 959

Schizophrenia (SCZ) is a chronic psychiatric disorder marked by cognitive, perceptual, and motivational deficits, exerting adverse effects on both individuals and society. Global statistics indicate that the lifetime prevalence of SCZ is approximately 5.5 per 1,000 people [1, 2]. According to the World...